Form D · Other Health Care

BioHorizons, Inc.

Birmingham, AL · CIK 0001492464

Offering snapshot reported Dec 19, 2012 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 18, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 19, 2012Initial$1,500,000No comparison33SEC filing
Nov 18, 2011Initial$12,558,512No comparison9SEC filing
Jul 29, 2011Initial$50,000,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-188611
Rolling Common Stock issued to certain existing securityholders as part of the settlement of a lawsuit.

Source: Form D, filed Dec 19, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Clark M. Barousse Executive
Mortimer Berkowitz Iii Director
Robert H. Blankemeyer Director
R. Steven Boggan Director, Executive
John J. Chopack, Jr. Director
Tom C. Davis Director
David P. Dutil Executive
John H. Foster Director
David J, Hogan Director
Kendyl D. Lowe Executive
Siri S. Marshall Director
Andrea G. Mc Caskey Executive
J. Todd Strong Executive
Barry Thornton Executive
David A. Wall Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2300 Riverchase Center
Birmingham, AL, 35244